1. Home
  2. SURG vs VNRX Comparison

SURG vs VNRX Comparison

Compare SURG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$0.88

Market Cap

18.3M

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
VNRX
Founded
2006
N/A
Country
United States
United States
Employees
20
N/A
Industry
Advertising
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3M
31.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
SURG
VNRX
Price
$0.88
$0.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$9.75
$2.50
AVG Volume (30 Days)
157.4K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,233,511.00
Revenue This Year
$3.78
$68.22
Revenue Next Year
$113.46
$382.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.10
52 Week Low
$0.75
$0.17
52 Week High
$3.47
$0.94

Technical Indicators

Market Signals
Indicator
SURG
VNRX
Relative Strength Index (RSI) 43.40 42.62
Support Level $0.75 $0.17
Resistance Level $0.95 $0.27
Average True Range (ATR) 0.06 0.02
MACD 0.03 0.00
Stochastic Oscillator 64.89 36.63

Price Performance

Historical Comparison
SURG
VNRX

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: